New here, trying to follow peptide approval talk without getting lost

2026-10-06 16:03

Hi everyone, I’m brand new and just finished my first week on this forum. I’m not looking for sources, doses, or anything like that.

I keep seeing references to peptides being approved in the U.S. versus something called a Category 1 review, and I honestly can’t tell where to even start reading.

Is there a plain-English way to understand the difference?

I logged my meals for five days and I’m still mostly just trying to learn the etiquette here, so I’d rather ask a small question than misunderstand a serious thread. Sorry if this has been covered elsewhere — I’d be grateful for a nudge in the right direction.

2026-10-11 01:01

Welcome — I remember that same fog. The way I keep it straight: “FDA-approved” is about a specific finished drug product with trials and a label.

“Category 1” is more of a regulatory bucket for ingredients being reviewed for compounding, not a synonym for approved. I’m in maintenance now and still keep a note on my phone with three columns: term, who regulates it, what it actually means for my routine.

That tiny habit stopped me from panicking at every headline. Which part is tripping you up more — the agency acronyms or how compounding fits in?

2026-10-13 16:01

“Approval” usually means a specific manufacturer got an NDA/BLA for a specific peptide product and indication. “Category 1” — if you mean the FDA 503A bulk-substance docket — is a different axis: it’s about whether a bulk ingredient can be used in compounding while FDA reviews it, not whether it’s been proven effective.

In the trials I’ve read, those two ideas get conflated constantly. I keep a two-column note: product approval vs. compounding-list status, because they answer different questions.

Which peptide were you reading about? If it’s the 503A list, start with the FDA’s category definitions page.